Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.200
-1.460-2.94%
Volume:10.03M
Turnover:484.39M
Market Cap:319.90B
PE:35.01
High:49.660
Open:49.660
Low:47.600
Close:49.660
52wk High:94.869
52wk Low:47.600
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:1.00
T/O Rate:3.89%
Dividend:0.23
Dividend Rate:0.47%
EPS(LYR):1.377
ROE:12.46%
ROA:7.02%
PB:4.25
PE(LYR):35.01
PS:8.75

Loading ...

JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis

Deep News
·
Aug 06

Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection

Stock News
·
Aug 06

Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing

THOMSON REUTERS
·
Aug 06

HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently

Deep News
·
Aug 06

Movement Alert|HENGRUI PHARMA Falls 3.09% in Regular Trading, Trading at HK$56.35

Market Focus
·
Aug 06

Cross-Market Valuation Disparities: Top A-H Share Premium Rankings as of August 5th

Stock News
·
Aug 05

Hengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials

MT Newswires Live
·
Aug 05

Hengrui Pharma Completes 13.75 Million Share Buyback as of July 31

Stock News
·
Aug 04

HENGRUI PHARMA's Subsidiary Secures Approval for Clinical Trial Initiation

Stock News
·
Aug 04

Hengrui Pharma Maintains Stable H-Share Base; Repurchases 0.28 Million A-Shares in July

Bulletin Express
·
Aug 04

Dual-Listed Stock Premium Snapshot: August 3 Market Close

Stock News
·
Aug 03

Metis TechBio Jumps on Jiangsu Hengrui-tie up on AI Formulation Platform

Reuters
·
Aug 03

METIS TECHBIO-P Deploys AI Drug Formulation Platform at HENGRUI PHARMA, Accelerating NanoForge Commercialization

Stock News
·
Aug 03

The Capital Group Companies Increases Stake in Hengrui Pharma with 483,600 Share Purchase at Approximately HK$57.90 Each

Deep News
·
Aug 03

AH Share Premium Rankings for July 31

Stock News
·
Jul 31

AH Share Premium Ranking Update: July 30 Market Close

Stock News
·
Jul 30

Movement Alert|HENGRUI PHARMA Falls 3.17% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure Despite Multiple Positive Catalysts

Market Focus
·
Jul 30

Hengrui Pharma Wins China Regulator's Nod for Three Drugs

MT Newswires Live
·
Jul 30

Capital Group Boosts Stake in Hengrui Pharma with 752,200 Share Purchase

Deep News
·
Jul 30

Hengrui Pharma Secures NMPA Nod for China’s First Home-grown Long-Acting Insulin Analog

Bulletin Express
·
Jul 29